Literature DB >> 33584676

Next Generation Imaging Techniques to Define Immune Topographies in Solid Tumors.

Violena Pietrobon1, Alessandra Cesano2, Francesco Marincola1, Jakob Nikolas Kather3,4.   

Abstract

In recent years, cancer immunotherapy experienced remarkable developments and it is nowadays considered a promising therapeutic frontier against many types of cancer, especially hematological malignancies. However, in most types of solid tumors, immunotherapy efficacy is modest, partly because of the limited accessibility of lymphocytes to the tumor core. This immune exclusion is mediated by a variety of physical, functional and dynamic barriers, which play a role in shaping the immune infiltrate in the tumor microenvironment. At present there is no unified and integrated understanding about the role played by different postulated models of immune exclusion in human solid tumors. Systematically mapping immune landscapes or "topographies" in cancers of different histology is of pivotal importance to characterize spatial and temporal distribution of lymphocytes in the tumor microenvironment, providing insights into mechanisms of immune exclusion. Spatially mapping immune cells also provides quantitative information, which could be informative in clinical settings, for example for the discovery of new biomarkers that could guide the design of patient-specific immunotherapies. In this review, we aim to summarize current standard and next generation approaches to define Cancer Immune Topographies based on published studies and propose future perspectives.
Copyright © 2021 Pietrobon, Cesano, Marincola and Kather.

Entities:  

Keywords:  deep learning; imaging techniques; immune exclusion; immune topography; single-cell analysis; solid tumors

Mesh:

Substances:

Year:  2021        PMID: 33584676      PMCID: PMC7873485          DOI: 10.3389/fimmu.2020.604967

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  387 in total

1.  Autonomous T cell trafficking examined in vivo with intravital two-photon microscopy.

Authors:  Mark J Miller; Sindy H Wei; Michael D Cahalan; Ian Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

Review 2.  Dynamic behavior of T cells and thymocytes in lymphoid organs as revealed by two-photon microscopy.

Authors:  Philippe Bousso; Ellen A Robey
Journal:  Immunity       Date:  2004-09       Impact factor: 31.745

Review 3.  Molecular basis and current strategies of therapeutic arginine depletion for cancer.

Authors:  Livingstone Fultang; Ashley Vardon; Carmela De Santo; Francis Mussai
Journal:  Int J Cancer       Date:  2016-04-15       Impact factor: 7.396

4.  Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.

Authors:  Chris J Scotton; Julia L Wilson; Kate Scott; Gordon Stamp; George D Wilbanks; Simon Fricker; Gary Bridger; Frances R Balkwill
Journal:  Cancer Res       Date:  2002-10-15       Impact factor: 12.701

Review 5.  TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy.

Authors:  Yemsratch T Akalu; Carla V Rothlin; Sourav Ghosh
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

6.  Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies.

Authors:  Richard Tavaré; Melissa N McCracken; Kirstin A Zettlitz; Felix B Salazar; Tove Olafsen; Owen N Witte; Anna M Wu
Journal:  J Nucl Med       Date:  2015-05-07       Impact factor: 10.057

7.  Collagen polymorphism in extracellular matrix of human osteosarcoma.

Authors:  F D Shapiro; D R Eyre
Journal:  J Natl Cancer Inst       Date:  1982-11       Impact factor: 13.506

8.  TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.

Authors:  Sanjeev Mariathasan; Shannon J Turley; Dorothee Nickles; Alessandra Castiglioni; Kobe Yuen; Yulei Wang; Edward E Kadel; Hartmut Koeppen; Jillian L Astarita; Rafael Cubas; Suchit Jhunjhunwala; Romain Banchereau; Yagai Yang; Yinghui Guan; Cecile Chalouni; James Ziai; Yasin Şenbabaoğlu; Stephen Santoro; Daniel Sheinson; Jeffrey Hung; Jennifer M Giltnane; Andrew A Pierce; Kathryn Mesh; Steve Lianoglou; Johannes Riegler; Richard A D Carano; Pontus Eriksson; Mattias Höglund; Loan Somarriba; Daniel L Halligan; Michiel S van der Heijden; Yohann Loriot; Jonathan E Rosenberg; Lawrence Fong; Ira Mellman; Daniel S Chen; Marjorie Green; Christina Derleth; Gregg D Fine; Priti S Hegde; Richard Bourgon; Thomas Powles
Journal:  Nature       Date:  2018-02-14       Impact factor: 49.962

Review 9.  Cell Tracking in Cancer Immunotherapy.

Authors:  Justine Perrin; Marisa Capitao; Marie Mougin-Degraef; François Guérard; Alain Faivre-Chauvet; Latifa Rbah-Vidal; Joëlle Gaschet; Yannick Guilloux; Françoise Kraeber-Bodéré; Michel Chérel; Jacques Barbet
Journal:  Front Med (Lausanne)       Date:  2020-02-14

10.  Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [18F]-labeled 2'-deoxycytidine analog.

Authors:  Caius G Radu; Chengyi J Shu; Evan Nair-Gill; Stephanie M Shelly; Jorge R Barrio; Nagichettiar Satyamurthy; Michael E Phelps; Owen N Witte
Journal:  Nat Med       Date:  2008-06-08       Impact factor: 53.440

View more
  2 in total

1.  The Future of Cancer Diagnosis, Treatment and Surveillance: A Systemic Review on Immunotherapy and Immuno-PET Radiotracers.

Authors:  Virginia Liberini; Riccardo Laudicella; Martina Capozza; Martin W Huellner; Irene A Burger; Sergio Baldari; Enzo Terreno; Désirée Deandreis
Journal:  Molecules       Date:  2021-04-11       Impact factor: 4.411

Review 2.  Dive into Single, Seek Out Multiple: Probing Cancer Metastases via Single-Cell Sequencing and Imaging Techniques.

Authors:  Shang Su; Xiaohong Li
Journal:  Cancers (Basel)       Date:  2021-03-03       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.